SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 0.690-2.8%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ralph Roessler who wrote (2822)11/5/1996 7:41:00 AM
From: H.J. Schellenberg   of 14328
 
You guys ARE truly hopeless.....

1. TRIBY's product is not in any way unique. Competitors are all over it with
similar, if not better, products. AVIT is only the latest in a long string of those
willing to take a bite out of the TRIBY cookie. My only point is that you ought
to price AVIT at least as high as TRIBY on a per share basis. They should be
trading at least in the $2-5 range.

2. Large companies cut deals with small fish like TRIBY all the time. The
reason is that these small companies are desparate to get sales. The little fish
cut their margins down to nothing just to do business with guys like Bayer.

FYI - EPT is getting undercut like crazy in all markets. The latest trick to boost
sales is a coupon which cuts the price to a bit above competitors. That is
going to fail, too as comsumers realize it still costs more for less product.
EPT is over and TRIBY is out on a limb now without other sales.

Look for big brother to renegotiate the EPT contract - best case.
Look for them to switch to another producer (maybe AVIT) - worst case.

Either way, this baby is going to $1, no matter what you guys say or do.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext